Lausanne is positioning itself at the forefront of fighting antibiotic resistance.
The University Hospital is now authorized to research bacteriophage medicines - these are viruses that attack a specific bacteria.
Scientists hope the treatment will be a successful addition to antibioptics - but far more work needs to be done.
The Lausanne hospital is making personalized medicines for specific patients - it’s the only public institution in the world authorized to manufacture phages.
New app launch in Neuchâtel
Rhône project consultation announced
Landmark store for Coop
Progress in Winter Olympics bid
Health insurance premium rises next year
No snow on Matterhorn
